Quick Answer
Xenetic Biosciences, Inc. reported Net Income Loss of -$2.68 million for the year ending 2025.
- Xenetic Biosciences, Inc. showed an increase of +32.3% in Net Income Loss from 2024 to 2025.
- This data is from Xenetic Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2011: -$18.2 thousand | Q4 2012: -$14.5 thousand | Q4 2013: -$82.5 thousand | Q1 2014: -$4.06 million | Q2 2014: -$2.76 million | Q3 2014: -$3.18 million | Q1 2015: -$2.43 million | Q2 2015: -$1.13 million | Q3 2015: -$5.32 million | Q1 2016: -$3.57 million | Q2 2016: -$47.77 million | Q3 2016: -$2.47 million | Q1 2017: -$2.87 million | Q2 2017: -$2.92 million | Q3 2017: -$2.26 million | Q1 2018: -$1.82 million | Q2 2018: -$2.03 million | Q3 2018: -$1.81 million | Q1 2019: -$1.33 million | Q2 2019: -$1.38 million | Q3 2019: -$8.90 million | Q1 2020: -$1.18 million | Q2 2020: -$953.6 thousand | Q3 2020: -$7.56 million | Q1 2021: -$1.35 million | Q2 2021: -$1.11 million | Q3 2021: -$1.35 million | Q1 2022: -$1.59 million | Q2 2022: -$2.67 million | Q3 2022: -$804.0 thousand | Q1 2023: -$856.6 thousand | Q2 2023: -$1.05 million | Q3 2023: -$1.06 million | Q1 2024: -$1.20 million | Q2 2024: -$1.27 million | Q3 2024: -$436.7 thousand | Q1 2025: -$903.1 thousand | Q2 2025: -$688.7 thousand | Q3 2025: -$509.9 thousand.
- Over the full 16 years of available data (2011 to 2025), Xenetic Biosciences, Inc.'s Net Income Loss has declined by 1,967.4%.
- Historical annual values: Fiscal year 2025: -$2.68 million | Fiscal year 2024: -$3.96 million | Fiscal year 2023: -$4.13 million | Fiscal year 2022: -$6.55 million | Fiscal year 2021: -$5.65 million | Fiscal year 2020: -$10.89 million | Fiscal year 2019: -$12.78 million | Fiscal year 2018: -$7.30 million | Fiscal year 2017: -$3.60 million | Fiscal year 2016: -$54.21 million | Fiscal year 2015: -$12.51 million | Fiscal year 2014: -$14.31 million | Fiscal year 2013: -$8.58 million | Fiscal year 2013: -$89.2 thousand | Fiscal year 2012: -$89.2 thousand | Fiscal year 2011: -$129.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: